Call the Myeloma Infoline
0800 980 3332
If you're affected by myeloma


Myeloma UK news

Nottingham Patient and Family Infoday a great success

Nottingham Patient and Family Infoday a great success

      On Saturday 24 March Myeloma UK held its third Patient and Family Myeloma Infoday of 2012 in Nottingham. Attended by over 75 patients, carers and family members, the day was expertly chaired by myeloma experts Prof Rusell and Dr Cathy Williams from Nottingham University Ho.....


Leeds Patient and Family Infoday a great success

On Saturday 24 March Myeloma UK held its second Patient and Family Myeloma Infoday of 2012 in Leeds. Attended by over 70 patients, carers and family members, the day was expertly chaired by myeloma expert Prof Gareth Morgan from The Royal Marsden Hospital in London. Joining him on the faculty was .....

Newcastle Patient and Family Infoday a great success

Newcastle Patient and Family Infoday a great success

On Saturday 3 March Myeloma UK held its first Patient and Family Myeloma Infoday of 2012 in Newcastle. Attended by over 80 patients, carers and family members, the day was expertly chaired by myeloma expert Prof Graham Jackson from the Freeman Hospital in Newcastle. Joining him on the faculty was .....


New Haematology Suite opens in Northampton

Myeloma UK welcomes the opening of the new Haematology Suite at Northampton General Hospital on Monday 6 February 2012. The £2.2 million unit will treat patients with myeloma and other blood cancers. The facility will reduce waiting times by increasing patient capacity and will provide a more.....


MUK one clinical trial re-opens

The first clinical study in the Myeloma UK Early Phase Clinical Trial Network, known as MUK one, has re-opened after a temporary pause in September 2011. The study aims to identify a suitable dose for bendamustine (a type of chemotherapy) when given in combination with thalidomide and dexamethasone,.....

Previous stories
1, 2, 3, 4, 5, 6